This vicious cycle between the up-regulation of SGLT2 and increases in blood glucose levels and the amount of body fluid synergistically exacerbate the pathophysiology of diabetic nephropathy and may contribute to the progression of kidney dysfunction. This evidence concerns the gene SLC5A2 and diabetic kidney disease.